Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database

No updated data on people living with HIV (PLHIV) in Japan have been available since 2015, leaving a critical gap in understanding the current status of care and treatment. Therefore, this study aimed to conduct a nationwide evaluation of the second and third goals of the "90-90-90 target" defined by UNAIDS between 2016 and 2020. The study utilized data from approximately 360 core hospitals through structured questionnaires and the National Database of Health Insurance Claims and Specific Health Checkups (NDB). Key findings revealed that over 95% of diagnosed outpatients were retained in care (second 90), and more than 99% achieved successful viral suppression (third 90). A significant transition to single-tablet regimens and newer, highly effective antiretroviral drugs was observed, optimizing treatment adherence and outcomes. These results underscore the efficacy of Japan's universal health insurance system in ensuring consistent access to HIV care and treatment, supporting both individual patient outcomes and national surveillance efforts.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2025-01-27
DOI
https://doi.org/10.1371/journal.pone.0317655
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database

Tomoya Myojin, Mayumi Imahashi, Tatsuya Noda, Tomoaki Imamura et al.
PLoS ONE
HIV/AIDS Research and Interventions
article

Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database

Tomoya Myojin, Mayumi Imahashi, Tatsuya Noda, Tomoaki Imamura, Yuichi Nishioka, Aikichi Iwamoto, Yoshiyuki Yokomaku
article en

Abstract

No updated data on people living with HIV (PLHIV) in Japan have been available since 2015, leaving a critical gap in understanding the current status of care and treatment. Therefore, this study aimed to conduct a nationwide evaluation of the second and third goals of the "90-90-90 target" defined by UNAIDS between 2016 and 2020. The study utilized data from approximately 360 core hospitals through structured questionnaires and the National Database of Health Insurance Claims and Specific Health Checkups (NDB). Key findings revealed that over 95% of diagnosed outpatients were retained in care (second 90), and more than 99% achieved successful viral suppression (third 90). A significant transition to single-tablet regimens and newer, highly effective antiretroviral drugs was observed, optimizing treatment adherence and outcomes. These results underscore the efficacy of Japan's universal health insurance system in ensuring consistent access to HIV care and treatment, supporting both individual patient outcomes and national surveillance efforts.

PLoS ONEVol. 20(1)
Japan Agency for Medical Research and Development (JP), Nagoya Medical Center (JP), Nara Medical University (JP)
Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 98%
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database — Tomoya Myojin, Mayumi Imahashi, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS